Edwards Lifesciences Opens New Regional Headquarters and Training Center in Nyon, Switzerland
NYON, SWITZERLAND, June 26, 2009 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic
monitoring, today announced the opening of its new regional headquarters in
Nyon, Switzerland. The facility will serve Edwards' growing Europe, Middle
East and Africa (EMEA) operations from a more central location, and
features a state-of-the-art training facility where physicians can educate
their peers on new technologies and techniques that have the potential to
drive better outcomes and lower costs.
"Edwards' new headquarters will help us accommodate our significant
regional growth in heart valves and critical care, and allow us to continue
benefiting from a favorable business climate," said Patrick B. Verguet,
Edwards' corporate vice president, Europe, Middle East and Africa. "We
look forward to expanding our commitment to training and education programs
by welcoming physicians and healthcare professionals to our new facility."
"We are pleased to welcome the global cardiovascular and critical care
technology innovator Edwards Lifesciences to Nyon. The city's economy will
benefit from not only the operation of the headquarters here, but also the
visitors Edwards expects for meetings and trainings at the new building,"
said Daniel Rossellat, Syndic of Nyon.
"The Canton de Vaud has established a strong presence of leading companies
like Edwards, and we look forward to the additional job and economic
development opportunities that will result from a thriving bio-medical
industry in this region. We are encouraged that companies like Edwards are
continuing to recruit new talent, even during a challenging global
economy," said Philippe Leuba, Conseiller d'Etat of Canton de Vaud.
In addition to an advanced training center, the Edwards facility features
an upgraded environment for more than 100 employees, including large work
spaces, a fitness center and healthy food options in the on-site café.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring, with more than five decades of experience in
partnering with clinicians to develop life-saving innovations.
Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular
disease with its market-leading heart valve therapies, and critical care
and vascular technologies, which are sold in approximately 100 countries.
The company's global brands include Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional
company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation; Edwards
Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are
trademarks of Edwards Lifesciences Corporation and are registered in the
United States Patent and Trademark Office.
# # #